Drug intelligence / Profile preview

Leviker

Development stage
Unknown
Lead developer
Stragen
Modality
Small Molecules
Administration
Oral
01

Overview

Leviker is a consumer health supplement developed by Stragen Pharma Group, designed to support liver function and metabolic health. It is primarily indicated for individuals with non-alcoholic fatty liver disease (NAFLD) or metabolic-associated fatty liver disease (MAFLD). The formulation consists of a standardized extract of *Prunus mume* (Japanese apricot), which contains bioactive triterpenoids such as oleanolic acid and ursolic acid, alongside choline bitartrate. These components work to reduce oxidative stress and inflammation in the liver while supporting normal lipid metabolism and preventing hepatic fat accumulation. Leviker is marketed as a natural approach to maintaining healthy liver enzyme levels (ALT and AST) and overall hepatic wellness.

Brand names
Leviker
Other names
Prunus mume extract + Choline
02

Targets

NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)NF-κB

Beyond the preview

Go deeper on Leviker.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leviker.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call